Catalent, Inc. (CTLT Quick QuoteCTLT - Free Report) was a big mover last session, as the company saw its shares rise more than 5% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, which remained volatile and traded within the range of $40.24–$43.98 in the past one-month time frame, witnessed a sharp increase yesterday.

The company has seen a mixed track record when it comes to estimate revision of one increase and three decreases over the past few weeks, while the Zacks Consensus Estimate for the current quarter remained unchanged. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Catalent currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Investors interested in the Medical - Drugs industry may consider Summit Therapeutics plc (SMMT Quick QuoteSMMT - Free Report) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is CTLT going up? Or down? Predict to see what others think:Up or Down

The Hottest Tech Mega-Trend of All

Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>